OTCMKTS:BVNRY Bavarian Nordic A/S (BVNRY) Stock Price, News & Analysis → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free BVNRY Stock Alerts $7.43 -0.03 (-0.40%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$7.31▼$7.4550-Day Range$7.34▼$8.5352-Week Range$5.95▼$10.65Volume1,189 shsAverage Volume5,648 shsMarket Capitalization$1.74 billionP/E Ratio7.82Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsHeadlinesShort InterestStock AnalysisChartEarningsHeadlinesShort Interest Get Bavarian Nordic A/S alerts: Email Address Ad DTIthe most reliable asset on earth is making a comebackGlobal tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal.And you can see how it works for FREE when you Click Here About Bavarian Nordic A/S Stock (OTCMKTS:BVNRY)Bavarian Nordic A/S is a fully-integrated biotechnology company focused on vaccination technology. The company’s work is built around two primary platforms that provide numerous benefits to the health industry and individuals. The company’s primary technology is MVA-BN which stands for Modified Vaccine Ankara-Bavarian Nordic. This vaccination platform is a non-replicating platform, meaning that live-virus vaccines cannot reproduce and spread within the host. This is central to the platform's high tolerance rate. MVA-BN is approved as a smallpox and monkeypox vaccine in the US, Canada, and the EU. It is also included in the US Strategic National Stockpile and is being used worldwide to control the 2022 Monkeypox outbreak.Bavarian Nordic is headquartered in Hellerup, Denmark with manufacturing sites in Denmark and Germany. The company maintains offices in Switzerland, the UK, Japan, and North Carolina in the United States. The company was incorporated in 1992 and had 4 approved products under 7 brand names available for use. Its MVA-BN non-replicating smallpox and monkeypox vaccines are available under the IMVAMUNE, IMVANEX and JYNNEOS names.The company’s second platform is the Vaccinia-Fowlpox-TRICOM platform for treating cancers. The platform can be targeted to attack specific markers found in numerous cancers. The company’s other marketable vaccines are Rabipur for rabies, MVABEA for Ebola and Marburg Hemorrhagic fever, and Encepur for tick-borne encephalitis.The company’s pipeline has 4 potential candidates for the market. These include a freeze-dried version of MVA-BN for smallpox, MVA-BN for RSV (respiratory infection), and TAEK-VAC for certain cancers. The company’s COVID-19/SARS vaccine boosters have shown effectiveness 6 months after dosing. Read More BVNRY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BVNRY Stock News HeadlinesMarch 21, 2024 | americanbankingnews.comBavarian Nordic A/S (OTCMKTS:BVNRY) Stock Price Crosses Below 200-Day Moving Average of $7.55March 16, 2024 | msn.comFrankenmuth kicks off the start of Osterbrunnen: Bavarian EasterMarch 28, 2024 | Behind the Markets (Ad)Urgent: Protect Your Investments from a Chinese InvasionAn alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.March 14, 2024 | wsj.comNordic Economic Growth to Pick Up This Year, But With DivergenceMarch 14, 2024 | wsj.comNordic Capital Bets on Digital Payments Backing InsurTech One IncMarch 13, 2024 | finance.yahoo.comBavarian Nordic Receives Approval of Smallpox and Mpox Vaccine in SwitzerlandMarch 12, 2024 | globenewswire.comReport of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with suchMarch 11, 2024 | msn.comHurry: Nordic Ware’s Spring-Themed Baking Pans Are Up to 45% Off, Just In Time To Celebrate the SeasonMarch 28, 2024 | WealthPress (Ad)A lot of people are making this costly mistakeYou may have heard the saying “options are risky” … And, they can be. But only if you use them the way a lot of folks do. A lot of people think of BUYING speculative options when they talk about options. And BUYING low probability, speculative options is definitely risky… It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. March 6, 2024 | finanznachrichten.deBavarian Nordic A/S: Bavarian Nordic Publishes Annual Report 2023March 6, 2024 | finance.yahoo.comBavarian Nordic Publishes Annual Report 2023February 25, 2024 | benzinga.comBavarian Nordic Stock (OTC:BVNRY) Dividends: History, Yield and DatesFebruary 23, 2024 | msn.comBavarian Nordic’s chikungunya vaccine secures EMA fast-trackFebruary 23, 2024 | finanznachrichten.deBavarian Nordic A/S: Bavarian Nordic's Chikungunya Vaccine Candidate Granted Accelerated Assessment by European Medicines AgencyFebruary 23, 2024 | finance.yahoo.comBavarian Nordic’s Chikungunya Vaccine Candidate Granted Accelerated Assessment by European Medicines AgencyFebruary 21, 2024 | msn.comBavarian Nordic pulls plug on cancer vaccine programFebruary 21, 2024 | finance.yahoo.comBavarian Nordic delivered record financial results in 2023February 21, 2024 | globenewswire.comBavarian Nordic delivered record financial results in 2023February 12, 2024 | investing.comBavarian Nordic A/S ADR (BVNRY)February 3, 2024 | msn.comMatch awards from Bayern Munich’s 3-1 comeback win against Borussia MönchengladbachFebruary 2, 2024 | msn.comBavarian Podcast Works: Preview Show — Bayern Munich vs. Gladbach (Bundesliga)January 30, 2024 | msn.com13 Icy Nordic Thrillers to Get You Through the WinterJanuary 22, 2024 | finance.yahoo.comReport of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with suchNovember 30, 2023 | finanznachrichten.deNasdaq Copenhagen A/S: Bavarian Nordic A/S - admittance to trading and official listing of new shares due to employees' exercise of warrantsNovember 28, 2023 | msn.comBavarian Nordic A (BVNRY) Price Target Increased by 77.07% to 23.20November 22, 2023 | finanznachrichten.deBavarian Nordic A/S: Bavarian Nordic to hold Capital Markets Days in February 2024November 22, 2023 | finance.yahoo.comBavarian Nordic to hold Capital Markets Days in February 2024See More Headlines Receive BVNRY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bavarian Nordic A/S and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/06/2024Today3/28/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolOTCMKTS:BVNRY CUSIPN/A CIKN/A Webwww.bavarian-nordic.com Phone(453) 326-8383Fax45-3326-8380Employees1,379Year Founded1994Profitability EPS (Most Recent Fiscal Year)$0.95 Trailing P/E Ratio7.82 Forward P/E Ratio13.04 P/E GrowthN/ANet Income$214.09 million Net Margins20.80% Pretax Margin12.92% Return on Equity0.07% Return on Assets14.62% Debt Debt-to-Equity RatioN/A Current Ratio1.55 Quick Ratio0.94 Sales & Book Value Annual Sales$1.02 billion Price / Sales1.70 Cash Flow$0.03 per share Price / Cash Flow215.56 Book Value$4.77 per share Price / Book1.56Miscellaneous Outstanding Shares234,290,000Free FloatN/AMarket Cap$1.74 billion OptionableNot Optionable Beta1.50 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesDr. Paul John Chaplin MSc (Age 57)Ph.D., CEO & President Comp: $2.13MMr. Henrik Juuel M.Sc. (Age 59)CFO & Executive VP Comp: $1.18MMr. Russell Thirsk M.Sc. (Age 56)Executive VP & COO Mr. Rolf Sass SørensenVice President of Investor Relations & CommunicationsMs. Anu Helena Kerns M.Sc. (Age 52)Executive VP and Chief People & Sustainability Officer Mr. Jean-Christophe May M.B.A. (Age 57)Pharm.D., Executive VP & Chief Commercial Officer Dr. Laurence De Moerlooze Ph.D. (Age 60)Executive VP & Chief Medical Officer More ExecutivesKey CompetitorsAmbrx BiopharmaNYSE:AMAM4D Molecular TherapeuticsNASDAQ:FDMTFusion PharmaceuticalsNASDAQ:FUSNInhibrxNASDAQ:INBXTwist BioscienceNASDAQ:TWSTView All Competitors BVNRY Stock Analysis - Frequently Asked Questions How have BVNRY shares performed in 2024? Bavarian Nordic A/S's stock was trading at $8.7450 at the start of the year. Since then, BVNRY shares have decreased by 15.0% and is now trading at $7.43. View the best growth stocks for 2024 here. How were Bavarian Nordic A/S's earnings last quarter? Bavarian Nordic A/S (OTCMKTS:BVNRY) issued its quarterly earnings results on Wednesday, March, 6th. The company reported $0.56 earnings per share for the quarter, topping analysts' consensus estimates of $0.44 by $0.12. The firm had revenue of $353.27 million for the quarter, compared to analysts' expectations of $340.71 million. Bavarian Nordic A/S had a trailing twelve-month return on equity of 0.07% and a net margin of 20.80%. How do I buy shares of Bavarian Nordic A/S? Shares of BVNRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:BVNRY) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryOnly a fool would buy Nvidia today… Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bavarian Nordic A/S Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.